Global klinefelter syndrome treatment Market Size, Share, Forecast Report, 2020-2027

Global klinefelter syndrome treatment market is expected to rise steadily at a CAGR of 5.1 % during forecast period of 2018 to 2023.

Klinefelter syndrome is a rare genetic condition that can be seen when a boy is born with an extra copy of the X chromosome. It is a common genetic condition affecting males. This syndrome adversely affects testicular growth, and this can result in smaller than normal testicles. Hence this led to lower production of the sex hormone testosterone. Klinefelter syndrome may cause reduced muscle mass, reduced body and facial hair, and enlarged breast tissue. The effects of Klinefelter syndrome vary, and is a very rare condition, not everyone with it develops with these symptoms. According to the National Human Genome Research Institute, Klinefelter syndrome is found in about 1 out of every 500 to 1,000 new born males.

According to the researchers of national human research institutes, the Klinefelter syndrome condition cannot be diagnosed easily, due to its unidentifiable symptoms and signs among males. The signs of this condition are different and also gets overlap with symptoms of other health disorders. Due to this, various healthcare organizations such as the NIH and FDA are increasing their awareness regarding this health disorder, by stressing the parents to conduct all kinds of health check-ups to identify this disease. This syndrome can be prevented if detected at early stage and also can be prevented from development. Moreover, the awareness among the population reading this syndrome is also increasing.
Segmentation:

Global klinefelter syndrome treatment market is segmented into treatment and end-users. Based on treatment type the market is further segmented into testosterone replacement therapy,

fertility treatment breast tissue removal and others.

Fertility treatment is further sub-segmented into surgeries and hormone treatments.

On basis of end-user market is further segmented into hospital and clinics, ambulatory surgeries, medical research centres, academic institutes others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The klinefelter syndrome treatment market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. US account for the largest share of traumatic brain injury market.

Key players:

Some of the key players in the global klinefelter syndrome treatment market is Allergan plc, AbbVie, Inc., Endo Pharmaceuticals, Inc., Kyowa Kirin International plc, Eli Lilly and Company, Mylan N.V., Lupin Pharmaceuticals, Pfizer, Inc.

Global klinefelter syndrome treatment market, by Treatment

Testosterone Replacement Therapy
Fertility Treatment

• Surgeries
• Hormone Treatments
• Others

Breast Tissue Removal
Others

Global klinefelter syndrome treatment market, by End-Users

• Hospital and Clinics
• Ambulatory Surgeries
• Medical Research Centers
• Academic Institutes
• Others

Global klinefelter syndrome treatment market, by Key Players

• Lupin Pharmaceuticals
• Allergan plc
• AbbVie, Inc
• Endo Pharmaceuticals, Inc.
• Kyowa Kirin International plc
• Eli Lilly and Company
• Pfizer, Inc.
• Mylan N.V.